These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Disulfide-crosslink scanning reveals prion-induced conformational changes and prion strain-specific structures of the pathological prion protein PrP Taguchi Y; Lu L; Marrero-Winkens C; Otaki H; Nishida N; Schatzl HM J Biol Chem; 2018 Aug; 293(33):12730-12740. PubMed ID: 29934306 [TBL] [Abstract][Full Text] [Related]
5. A stretch of residues within the protease-resistant core is not necessary for prion structure and infectivity. Munoz-Montesino C; Sizun C; Moudjou M; Herzog L; Reine F; Igel-Egalon A; Barbereau C; Chapuis J; Ciric D; Laude H; Béringue V; Rezaei H; Dron M Prion; 2017 Jan; 11(1):25-30. PubMed ID: 28281924 [TBL] [Abstract][Full Text] [Related]
6. beta-sheet constitution of prion proteins. Ji HF; Zhang HY Trends Biochem Sci; 2010 Mar; 35(3):129-34. PubMed ID: 20060302 [TBL] [Abstract][Full Text] [Related]
7. Prion Protein Devoid of the Octapeptide Repeat Region Delays Bovine Spongiform Encephalopathy Pathogenesis in Mice. Hara H; Miyata H; Das NR; Chida J; Yoshimochi T; Uchiyama K; Watanabe H; Kondoh G; Yokoyama T; Sakaguchi S J Virol; 2018 Jan; 92(1):. PubMed ID: 29046443 [TBL] [Abstract][Full Text] [Related]
8. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region. Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632 [TBL] [Abstract][Full Text] [Related]
9. A seven-residue deletion in PrP leads to generation of a spontaneous prion formed from C-terminal C1 fragment of PrP. Munoz-Montesino C; Larkem D; Barbereau C; Igel-Egalon A; Truchet S; Jacquet E; Nhiri N; Moudjou M; Sizun C; Rezaei H; Béringue V; Dron M J Biol Chem; 2020 Oct; 295(41):14025-14039. PubMed ID: 32788216 [TBL] [Abstract][Full Text] [Related]
10. Mouse prion protein (PrP) segment 100 to 104 regulates conversion of PrP(C) to PrP(Sc) in prion-infected neuroblastoma cells. Hara H; Okemoto-Nakamura Y; Shinkai-Ouchi F; Hanada K; Yamakawa Y; Hagiwara K J Virol; 2012 May; 86(10):5626-36. PubMed ID: 22398286 [TBL] [Abstract][Full Text] [Related]
11. Toward the molecular basis of inherited prion diseases: NMR structure of the human prion protein with V210I mutation. Biljan I; Ilc G; Giachin G; Raspadori A; Zhukov I; Plavec J; Legname G J Mol Biol; 2011 Sep; 412(4):660-73. PubMed ID: 21839748 [TBL] [Abstract][Full Text] [Related]
12. Conformational conversion of prion protein in prion diseases. Zhou Z; Xiao G Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):465-76. PubMed ID: 23580591 [TBL] [Abstract][Full Text] [Related]
13. Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion. Biasini E; Medrano AZ; Thellung S; Chiesa R; Harris DA J Neurochem; 2008 Mar; 104(5):1293-308. PubMed ID: 18034781 [TBL] [Abstract][Full Text] [Related]
14. Disease-associated F198S mutation increases the propensity of the recombinant prion protein for conformational conversion to scrapie-like form. Vanik DL; Surewicz WK J Biol Chem; 2002 Dec; 277(50):49065-70. PubMed ID: 12372829 [TBL] [Abstract][Full Text] [Related]
15. Characterization of 2'-fluoro-RNA aptamers that bind preferentially to disease-associated conformations of prion protein and inhibit conversion. Rhie A; Kirby L; Sayer N; Wellesley R; Disterer P; Sylvester I; Gill A; Hope J; James W; Tahiri-Alaoui A J Biol Chem; 2003 Oct; 278(41):39697-705. PubMed ID: 12902353 [TBL] [Abstract][Full Text] [Related]
16. Prion proteins leading to neurodegeneration. La Mendola D; Pietropaolo A; Pappalardo G; Zannoni C; Rizzarelli E Curr Alzheimer Res; 2008 Dec; 5(6):579-90. PubMed ID: 19075585 [TBL] [Abstract][Full Text] [Related]
17. Biological and biochemical characterization of mice expressing prion protein devoid of the octapeptide repeat region after infection with prions. Yamaguchi Y; Miyata H; Uchiyama K; Ootsuyama A; Inubushi S; Mori T; Muramatsu N; Katamine S; Sakaguchi S PLoS One; 2012; 7(8):e43540. PubMed ID: 22927985 [TBL] [Abstract][Full Text] [Related]
18. Amino acid sequence and prion strain specific effects on the in vitro and in vivo convertibility of ovine/murine and bovine/murine prion protein chimeras. Kupfer L; Eiden M; Buschmann A; Groschup MH Biochim Biophys Acta; 2007 Jun; 1772(6):704-13. PubMed ID: 17145171 [TBL] [Abstract][Full Text] [Related]
19. Prion protein and its conformational conversion: a structural perspective. Surewicz WK; Apostol MI Top Curr Chem; 2011; 305():135-67. PubMed ID: 21630136 [TBL] [Abstract][Full Text] [Related]
20. Thermodynamic stabilization of the folded domain of prion protein inhibits prion infection in vivo. Kong Q; Mills JL; Kundu B; Li X; Qing L; Surewicz K; Cali I; Huang S; Zheng M; Swietnicki W; Sönnichsen FD; Gambetti P; Surewicz WK Cell Rep; 2013 Jul; 4(2):248-54. PubMed ID: 23871665 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]